174 related articles for article (PubMed ID: 11230998)
1. Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats.
Villegas I; Alarcón de la Lastra C; La Casa C; Motilva V; Martín MJ
Eur J Pharmacol; 2001 Feb; 414(1):79-86. PubMed ID: 11230998
[TBL] [Abstract][Full Text] [Related]
2. Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study.
Villegas I; Martín MJ; La Casa C; Motilva V; De La Lastra CA
Free Radic Res; 2002 Jul; 36(7):769-77. PubMed ID: 12180128
[TBL] [Abstract][Full Text] [Related]
3. Effects of meloxicam on oxygen radical generation in rat gastric mucosa.
Villegas I; Martín MJ; La Casa C; Motilva V; Alarcón de la Lastra C
Inflamm Res; 2000 Jul; 49(7):361-6. PubMed ID: 10959558
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
5. Gastric damage induced by subchronic administration of preferential cyclooxygenase-1 and cyclooxygenase-2 inhibitors in rats.
Villegas I; Alarcón de la Lastra C; Martín MJ; Motilva V; La Casa García C
Pharmacology; 2002 Oct; 66(2):68-75. PubMed ID: 12207113
[TBL] [Abstract][Full Text] [Related]
6. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach.
Ogino K; Hatanaka K; Kawamura M; Ohno T; Harada Y
Pharmacology; 2000 Nov; 61(4):244-50. PubMed ID: 11093076
[TBL] [Abstract][Full Text] [Related]
7. Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of prostaglandins and inflammatory response.
Villegas I; La Casa C; de la Lastra CA; Motilva V; Herrerías JM; Martín MJ
Life Sci; 2004 Jan; 74(7):873-84. PubMed ID: 14659976
[TBL] [Abstract][Full Text] [Related]
8. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
9. Melatonin protects against piroxicam-induced gastric ulceration.
Bandyopadhyay D; Ghosh G; Bandyopadhyay A; Reiter RJ
J Pineal Res; 2004 Apr; 36(3):195-203. PubMed ID: 15009511
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of meloxicam, celecoxib, and ibuprofen on free radical metabolism in human erythrocytes.
Burak Cimen MY; Cimen OB; Eskandari G; Sahin G; Erdoğan C; Atik U
Drug Chem Toxicol; 2003 Aug; 26(3):169-76. PubMed ID: 12953657
[TBL] [Abstract][Full Text] [Related]
11. Gastric toxicity of racemic ketoprofen and its enantiomers in rat: oxygen radical generation and COX-expression.
Alarcón de la Lastra C; Nieto A; Martín MJ; Cabré F; Herrerías JM; Motilva V
Inflamm Res; 2002 Feb; 51(2):51-7. PubMed ID: 11930903
[TBL] [Abstract][Full Text] [Related]
12. Effects of celecoxib on acid-challenged gastric mucosa of rats: comparison with metamizol and piroxicam.
Berenguer B; Alarcón De La Lastra C; Motilva V; La Casa C; Herrerias JM; Pozo D; Calero MJ
Dig Dis Sci; 2004 Jun; 49(6):937-47. PubMed ID: 15309881
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic response to increased pressure is preserved with COX-2 inhibitors.
Gross JM; Dwyer JE; Knox FG
Hypertension; 1999 Nov; 34(5):1163-7. PubMed ID: 10567199
[TBL] [Abstract][Full Text] [Related]
14. Intestinal toxicity of ketoprofen-trometamol vs its enantiomers in rat. Role of oxidative stress.
de la Lastra CA; Nieto A; Motilva V; Martín MJ; Herrerías JM; Cabré F; Mauleón D
Inflamm Res; 2000 Nov; 49(11):627-32. PubMed ID: 11131303
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
Lipscomb GR; Wallis N; Armstrong G; Rees WD
Br J Clin Pharmacol; 1998 Aug; 46(2):133-7. PubMed ID: 9723821
[TBL] [Abstract][Full Text] [Related]
16. Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.
Engelhardt G; Bögel R; Schnitzler C; Utzmann R
Biochem Pharmacol; 1996 Jan; 51(1):29-38. PubMed ID: 8534265
[TBL] [Abstract][Full Text] [Related]
17. The in vitro effects of piroxicam and meloxicam on canine cell lines.
Knottenbelt C; Chambers G; Gault E; Argyle DJ
J Small Anim Pract; 2006 Jan; 47(1):14-20. PubMed ID: 16417605
[TBL] [Abstract][Full Text] [Related]
18. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Stachura J; Pajdo R; Hahn EG
Eur J Pharmacol; 1999 Nov; 385(1):47-61. PubMed ID: 10594344
[TBL] [Abstract][Full Text] [Related]
19. Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
Berenguer B; Alarcón de la Lastra C; Moreno FJ; Martín MJ
Eur J Pharmacol; 2002 May; 442(1-2):125-35. PubMed ID: 12020690
[TBL] [Abstract][Full Text] [Related]
20. [Therapy with preferential and specific COX-2 inhibitors].
Stichtenoth DO; Frölich JC
Internist (Berl); 2001 Mar; 42(3):421-6. PubMed ID: 11277028
[No Abstract] [Full Text] [Related]
[Next] [New Search]
